exceet Group SCA

  • WKN: A0YF5P
  • ISIN: LU0472835155
  • Land: Luxemburg

Nachricht vom 29.06.2021 | 09:38

exceet Group SCA: exceet prepares potential sale of Lucom GmbH Elektrokomponenten und Systeme

exceet Group SCA / Key word(s): Disposal/Disposal
exceet Group SCA: exceet prepares potential sale of Lucom GmbH Elektrokomponenten und Systeme

29-Jun-2021 / 09:38 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Ad hoc Announcement

exceet prepares potential sale of Lucom GmbH Elektrokomponenten und Systeme

Grevenmacher, 29 June 2021 - The general partner of exceet Group SCA ("exceet") today resolved to start a structured sales process with regards to the potential sale of its portfolio company Lucom GmbH Elektrokomponenten und Systeme, Fürth ("Lucom"). The company operating in the field of mobile communications and automation and security technology generated revenues of EUR 5.4 million and an operating profit (EBITDA)1) of EUR 0.7 million in the financial year 2020. A decision as to whether and at which date the sale will take place has not yet been made. Following the completion of the sale of GS Swiss PCB AG (announced on 17 May 2021) and the sale of Lucom, exceet would no longer hold any operating companies. exceet is currently evaluating various strategic options with regard to its future.

1) Earnings before Interest, Taxes, Depreciation and Amortization (see pages 102 -105 "Alternative Performance Measures" of the Annual Report 2020

Further information:

Hendrik von Gregory
Email: investor.relations@exceet.com
exceet Group SCA
17, rue de Flaxweiler
L-6776 Grevenmacher
Telefon +352 28 38 47 20

ISIN: LU0472835155
Listed: Regulated Market of the Frankfurt Stock Exchange (Prime Standard)

About exceet
exceet is a listed holding company pursuing an opportunistic investment approach without a defined investment strategy. The investment focus is on seizing attractive risk / reward profiles without restrictions regarding the asset class, structure or duration of such investments.

29-Jun-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie


Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021